Over the course of her career, Bobbi Chapman has developed a keen understanding of how women struggle with heart issues that arise, or worsen, during pregnancies.
What's frustrating to Chapman, a cardiologist and medical director for heart failure at Massachusetts-based med-tech company Abiomed, is the lack of technology to help medical professionals intervene before such conditions turn fatal.
"I can tell you, as a physician, there's nothing more devastating than having a young mother come in with a disease that is fatal, and you — if you had seen her even days or weeks or months earlier — you could have prevented an untimely death and prevented leaving a newborn without a mother," Chapman said.
Inside a small suite at the 4Front Technology campus in Oakdale, a group of healthcare professionals are developing a system designed to curb a discouraging trend in heart failures among pregnant women.
Spun out of Mayo Clinic in 2018, Marani Health, previously called Odonata Health Inc., is piloting an in-home prenatal and postpartum care system that uses an artificial intelligence application for measuring the heart rates of pregnant women and their unborn fetus. The device also monitors contractions.
A limited supply of in-home telehealth systems for pregnant women — coupled with little to no input from women in clinical trials, which are predominantly tested on white men— has led to a lack of clinical research and innovation around maternal health, said Chapman, who also leads the company's Women's Heart Initiative.
Marani's ability to send physicians real-time data about how patients are doing in their homes helps close the gap in maternal care, especially with high-risk patients, Chapman said.
U.S. maternal mortality is on the rise. In 2021, 1,205 women in the U.S. died of maternal causes, which the National Center for Health Statistics determines are deaths of women while pregnant or within 42 days of termination of a pregnancy. That's up from 861 maternal deaths in 2020, and 754 in 2019.